Otsuka Holdings Co. Ltd. | Ownership
Companies that own Otsuka Holdings Co. Ltd.
Nomura Asset Management Co., Ltd.
19,736,695
3.54%
191,867
0.52%
07/31/2018
The Vanguard Group, Inc.
10,394,022
1.86%
-12,200
0.02%
07/31/2018
Daiwa Asset Management Co. Ltd.
8,213,997
1.47%
-85,603
0.44%
07/31/2018
Nikko Asset Management Co., Ltd.
8,041,899
1.44%
-19,201
0.22%
09/07/2018
BlackRock Fund Advisors
7,457,531
1.34%
8,000
0.02%
09/06/2018
Norges Bank Investment Management
5,424,259
0.97%
-335,095
0.04%
12/31/2017
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
4,182,806
0.75%
-181,894
0.42%
07/31/2018
Daiwa SB Investments Ltd.
2,161,898
0.39%
-731,002
1.14%
09/11/2018
JPMorgan Asset Management (UK) Ltd.
1,947,497
0.35%
-6,404
0.08%
09/06/2018
Amundi Asset Management SA (Investment Management)
1,890,871
0.34%
4,807
0.14%
08/29/2018
| Address |
Shinagawa Grand Central Tower, 12/F
Tokyo Tokyo 108
Japan
|
|
Employees
|
- |
| Website |
http://www.otsuka.com |
| Updated |
07/08/2019 |
| Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. |
